Robbert G. M. Bredius

9.5k citations
127 papers · 4.2k · h-index 36

Impact in

Papers in

  • Hematology 54
    • Hematopoietic Stem Cell Transplantation 46
    • Acute Myeloid Leukemia Research 9
  • Immunology 50
    • Immunodeficiency and Autoimmune Disorders 28
    • Immune Cell Function and Interaction 14
    • T-cell and B-cell Immunology 8
Co-authors
Arjan C. Lankester (52 shared papers)Maarten J. D. van Tol (24 shared papers)Jaap Jan Boelens (17 shared papers)T.A. Out (5 shared papers)Ron S. Weening (6 shared papers)Charlotte van Kesteren (9 shared papers)Catherijne A. J. Knibbe (9 shared papers)Rick Admiraal (12 shared papers)
Journals
Bone Marrow Transplantation (14 papers)Biology of Blood and Marrow Transplantation (12 papers)Journal of Clinical Immunology (5 papers)European Journal of Pediatrics (5 papers)Blood (3 papers)
Partner nations
NetherlandsUnited StatesUnited Kingdom

In The Last Decade

Robbert G. M. Bredius

125 papers receiving 4.1k citations

Peers

Robbert G. M. Bredius
Comparison fields: 5 of 110
  • Hematology 1.5k
  • Transplantation 213
  • Immunology 1.4k
  • Genetics 257
  • Oncology 645
Replace Martin Stern with:
Martin Stern Switzerland
Robert J. Hartzman United States
Trudy N. Small United States
Jaak M. Vossen Netherlands
Phillip Scheinberg United States
Bénédicte Neven France
Richard J. Benjamin United States
Jon J. van Rood Netherlands
Sébastien Maury France
Robertson Parkman United States
Robbert G. M. Bredius relative to Martin Stern Switzerland Martin Stern's profile →
Citations per field
00.5×1.5×1.8×
Martin Stern · 1×
Citations per year

Countries citing papers authored by Robbert G. M. Bredius

Since Specialization
Citations

This map shows the geographic impact of Robbert G. M. Bredius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robbert G. M. Bredius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robbert G. M. Bredius more than expected).

Fields of papers citing papers by Robbert G. M. Bredius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robbert G. M. Bredius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robbert G. M. Bredius. The network helps show where Robbert G. M. Bredius may publish in the future.

Co-authors

The 25 scholars most cited alongside Robbert G. M. Bredius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robbert G. M. Bredius Line = papers co-authored together Robbert G. M. Bredius links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL
Nature Genetics ·Cristina Sobacchi, Annalisa Frattini, Matteo M. Guerrini, Mario Abinun, Alessandra Pangrazio, (unknown), Robbert G. M. Bredius, Grazia M.S. Mancini, Andrew J. Cant, Nick Bishop, Peter Grabowski, Andrea Del Fattore, Chiara Messina, Gabriella Errigo, Fraser P. Coxon, Debbie I Scott, Anna Teti, Michael J. Rogers, Paolo Vezzoni, Anna Villa, Miep Helfrich
2007275
2
Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis
The Lancet Haematology ·Rick Admiraal, Charlotte van Kesteren, Cornelia M. Jol‐van der Zijde, Arjan C. Lankester, Marc Bierings, Toine C. G. Egberts, Maarten J. D. van Tol, Catherijne A. J. Knibbe, Robbert G. M. Bredius, Jaap Jan Boelens
2015202
3
Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes.
PubMed ·Robbert G. M. Bredius, C. A. P. Fijen, Masja de Haas, Ed J. Kuijper, Ron S. Weening, J G van de Winkel, T.A. Out
1994154
4
Fca Receptor Iia (Cd32) Polymorphism In Fulminant Meningococcal Septic
The Journal of Infectious Diseases ·Robbert G. M. Bredius, B. Derkx, C. A. P. Fijen, Ton P. M. de Wit, Masja de Haas, Ron S. Weening, Jan G. J. van de Winkel, T.A. Out
1994148
5
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis
The Lancet Haematology ·Rick Admiraal, Stefan Nierkens, Moniek A. de Witte, Eefke Petersen, Ger-Jan Fleurke, Luka Verrest, Svetlana V. Belitser, Robbert G. M. Bredius, Reinier Raymakers, Catherijne A. J. Knibbe, Monique C. Minnema, Charlotte van Kesteren, Jürgen Kuball, Jaap Jan Boelens
2017142
6
Body Weight-Dependent Pharmacokinetics of Busulfan in Paediatric Haematopoietic Stem Cell Transplantation Patients
Clinical Pharmacokinetics ·Imke H. Bartelink, Jaap Jan Boelens, Robbert G. M. Bredius, Toine C. G. Egberts, Chenguang Wang, Marc Bierings, Peter J. Shaw, Christa E. Nath, G. Hempel, J. Zwaveling, Meindert Danhof, Catherijne A. J. Knibbe
2012115
7
Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2.
The Journal of Immunology ·Robbert G. M. Bredius, C E de Vries, Annet Troelstra, L van Alphen, Ron S. Weening, J G van de Winkel, T.A. Out
1993101
8
The Same IκBα Mutation in Two Related Individuals Leads to Completely Different Clinical Syndromes
The Journal of Experimental Medicine ·Riny Janssen, Annelies van Wengen, Marieke A. Hoeve, Monique ten Dam, Miriam van der Burg, Jacques J. M. van Dongen, Esther van de Vosse, Maarten van Tol, Robbert G. M. Bredius, Tom H. M. Ottenhoff, Corry M.R. Weemaes, Jaap T. van Dissel, Arjan C. Lankester
200497
9
Effect of Ribavirin on the Plasma Viral DNA Load in Patients with Disseminating Adenovirus Infection
Clinical Infectious Diseases ·Arjan C. Lankester, Bianca Heemskerk, Eric C. J. Claas, Marco W. Schilham, Matthias F. C. Beersma, Robbert G. M. Bredius, Maarten J. D. van Tol, Aloys C.M. Kroes
200496
10
Prospective study of renal insufficiency after bone marrow transplantation
Pediatric Nephrology ·Joana Kist-van Holthe, C A Goedvolk, Ronald Brand, Margreet van Weel, Robbert G. M. Bredius, Jacques A. van Oostayen, Jacques Vossen, Bert van der Heijden
200289
11
Complete Suppression of the Gut Microbiome Prevents Acute Graft-Versus-Host Disease following Allogeneic Bone Marrow Transplantation
PLoS ONE ·Jaak M. Vossen, Harry F. L. Guiot, Arjan C. Lankester, Ann C.T.M. Vossen, Robbert G. M. Bredius, Ron Wolterbeek, Hanny D. J. Bakker, Peter J. Heidt
201478
12
Population Pharmacokinetic Modeling of Thymoglobulin® in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing
Clinical Pharmacokinetics ·Rick Admiraal, Charlotte van Kesteren, Cornelia M. Jol‐van der Zijde, Maarten J. D. van Tol, Imke H. Bartelink, Robbert G. M. Bredius, Jaap Jan Boelens, Catherijne A. J. Knibbe
201475
13
How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!
Bone Marrow Transplantation ·Martin B.A. Heemskerk, Suzanna M. van Walraven, J.J. Cornelissen, R M Y Barge, Robbert G. M. Bredius, R. Maarten Egeler, J.L.W.T. Lie, Tom Révész, K. Sintnicolaas, N. M. Wulffraat, Albertine E. Donker, Peter M. Hoogerbrugge, J. J. van Rood, Frans H.J. Claas, Machteld Oudshoorn
200574
14
Glutathione S-transferase Polymorphisms Are Not Associated With Population Pharmacokinetic Parameters of Busulfan in Pediatric Patients
Therapeutic Drug Monitoring ·J. Zwaveling, Rogier R. Press, Robbert G. M. Bredius, Tahar R J H M van derStraaten, Jan den Hartigh, Imke H. Bartelink, Jaap Jan Boelens, Henk‐Jan Guchelaar
200873
15
Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity
Bone Marrow Transplantation ·J. Zwaveling, Robbert G. M. Bredius, S C L M Cremers, L.M. Ball, Arjan C. Lankester, I M Teepe-Twiss, R. Maarten Egeler, Jan den Hartigh, Jaak M. Vossen
200465
16
Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer
Leukemia ·Karin Pike‐Overzet, Mark Rodijk, Y-Y Ng, Miranda R.M. Baert, Chantal Lagresle‐Peyrou, Axel Schambach, F. Zhang, Rob C. Hoeben, Salima Hacein‐Bey‐Abina, Arjan C. Lankester, Robbert G. M. Bredius, Gertjan J. A. Driessen, Adrian J. Thrasher, Christel Baum, Marina Cavazzana, Jacques J. M. van Dongen, Frank J. T. Staal
201164
17
Once-Daily Intravenous Busulfan with Therapeutic Drug Monitoring Compared to Conventional Oral Busulfan Improves Survival and Engraftment in Children Undergoing Allogeneic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation ·Imke H. Bartelink, Robbert G. M. Bredius, Tessa T. Ververs, Martine F. Raphaël, Charlotte van Kesteren, Marc Bierings, Carin M. A. Rademaker, Jan den Hartigh, Cuno S.P.M. Uiterwaal, J. Zwaveling, Jaap Jan Boelens
200759
18
Impact of Serotherapy on Immune Reconstitution and Survival Outcomes After Stem Cell Transplantations in Children: Thymoglobulin Versus Alemtuzumab
Biology of Blood and Marrow Transplantation ·Laura M. Willemsen, Cornelia M. Jol‐van der Zijde, Rick Admiraal, Hein Putter, Anja M. Jansen-Hoogendijk, Monique M. Ostaijen-ten Dam, Juul Wijnen, Charlotte van Kesteren, Jacqueline L.m. Waaijer, Arjan C. Lankester, Robbert G. M. Bredius, Maarten J. D. van Tol
201457
19
A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency
Clinical & Experimental Immunology ·Sandra Ammann, Rasmus Christian Elling, Mads Gyrd‐Hansen, Gregor Dückers, Robbert G. M. Bredius, Siobhan O. Burns, David Edgar, Austen Worth, Heide Brandau, Klaus Warnatz, Udo zur Stadt, Peter Hasselblatt, Klaus Schwarz, Stephan Ehl, Carsten Speckmann
201457
20
Primary immunodeficiencies in the Netherlands: National patient data demonstrate the increased risk of malignancy
Clinical Immunology ·(unknown), J. Merlijn van den Berg, Ineke J. M. ten Berge, Robbert G. M. Bredius, Gertjan J. Driessen, Virgil A. S. H. Dalm, Jaap T. van Dissel, Marcel van Deuren, Pauline M. Ellerbroek, Michiel van der Flier, P. Martin van Hagen, Joris M. van Montfrans, Abraham Rutgers, Elisabeth H. Schölvinck, Esther de Vries, R.T. van Beem, Taco W. Kuijpers
201456

About Robbert G. M. Bredius

Robbert G. M. Bredius is a scholar working on Hematology, Immunology, Epidemiology, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 127 papers that have together received 4.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (46 papers), Immunodeficiency and Autoimmune Disorders (28 papers), Acute Lymphoblastic Leukemia research (15 papers), Immune Cell Function and Interaction (14 papers), Renal Transplantation Outcomes and Treatments (9 papers), Acute Myeloid Leukemia Research (9 papers), T-cell and B-cell Immunology (8 papers) and Cytomegalovirus and herpesvirus research (8 papers). The work is most often cited by research in Hematology (1.5k citations), Transplantation (213 citations), Immunology (1.4k citations), Genetics (257 citations) and Oncology (645 citations). Robbert G. M. Bredius has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Arjan C. Lankester, Maarten J. D. van Tol, Jaap Jan Boelens, T.A. Out, Ron S. Weening, Charlotte van Kesteren, Catherijne A. J. Knibbe, Rick Admiraal, Cornelia M. Jol‐van der Zijde and J. Zwaveling. Their work appears in journals such as Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, Journal of Clinical Immunology, European Journal of Pediatrics and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin SternBreakdown of academic impact, for papers by Robert J. HartzmanBreakdown of academic impact, for papers by Trudy N. SmallBreakdown of academic impact, for papers by Jaak M. VossenBreakdown of academic impact, for papers by Phillip ScheinbergBreakdown of academic impact, for papers by Bénédicte NevenBreakdown of academic impact, for papers by Richard J. BenjaminBreakdown of academic impact, for papers by Jon J. van RoodBreakdown of academic impact, for papers by Sébastien MauryBreakdown of academic impact, for papers by Robertson Parkman